An executive at MPLT has sold a small portion of their shareholdings in a transaction valued at approximately $88,000. The divestment occurs as the market anticipates the release of clinical trial data in 2026.
- Sale of 3,316 shares executed on April 15, 2026
- Average transaction price of $26.61 per share
- Total divestment value of approximately $88,000
- Transaction occurs prior to 2026 trial data release
- Sale volume is considered low relative to total holdings
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.